Drug Metabolism and Pharmacokinetics
Online ISSN : 1880-0920
Print ISSN : 1347-4367
ISSN-L : 1347-4367
Regular Articles
Decreased Intestinal CYP3A and P-glycoprotein Activities in Rats with Adjuvant Arthritis
Satoshi UNOAtsushi KAWASEAkiko TSUJITadatoshi TANINOMasahiro IWAKI
Author information
JOURNAL FREE ACCESS

2007 Volume 22 Issue 4 Pages 313-321

Details
Abstract

  Adjuvant-induced arthritis (AA) rats have been used as an animal model for rheumatoid arthritis. Several studies have shown that the pharmacokinetics of a number of drugs are altered in AA rats. We investigated the effects of AA on the barrier functions of the intestine using a rat model.
   Intestinal CYP3A activities (midazolam 1′-hydroxylation and 7-benzyloxy-4-(trifluoromethyl)-coumarin 7-hydroxylation) in AA rats were significantly decreased compared with those in normal rats, with marked decrease observed in the upper segment of intestine. Intestinal P-glycoprotein (P-gp) activitiy at upper segment was also significantly decreased in AA rats to 60% of that in normal rats, and the other segments (middle and lower) of intestine also exhibited tendencies toward decrease in P-gp activity. This decrease was supported by the finding that levels of mdr1a mRNA and P-gp protein were decreased in AA rats. No significant differences were observed in intestinal paracellular and transcellular permeability between AA and normal rats.
   These results suggest that intestinal CYP3A and P-gp activities are decreased in AA rats, and that the pharmacokinetics and bioavailabilities of drugs whose membrane permeation is limited by intestinal CYP3A and/or P-gp may be altered in rheumatic diseases.

Content from these authors

This article cannot obtain the latest cited-by information.

© 2007 by The Japanese Society for the Study of Xenobiotics
Previous article Next article
feedback
Top